Reversible and Selective MAOIs in Combination with (S)SRIs: Risk of Serotonin Toxicity

These commentaries are based on Dr Gillman’s peer reviewed scientific papers, see Publications, and include a downloadable PDF.MoclobemideAbstractTherapeutic doses of Moclobemide combined with any (S)SRI carries a significant risk of…

Continue ReadingReversible and Selective MAOIs in Combination with (S)SRIs: Risk of Serotonin Toxicity